43 results
Page 2 of 3
S-3
EX-4.4
2e0se
9 Nov 22
Shelf registration
7:53am
S-3
EX-4.5
h2s kp370u
9 Nov 22
Shelf registration
7:53am
8-K
EX-10.1
z8cu8 a6p1gsj8
12 Sep 22
TScan Therapeutics Secures Convertible Debt Facility for up to $60 Million with K2 HealthVentures
7:51am
8-K
EX-99.1
19j fbicu
9 May 22
TScan Therapeutics Reports First Quarter 2022 Financial Results and Upcoming Anticipated Milestones
7:08am
DEF 14A
58tep5ftmoapylc
21 Apr 22
Definitive proxy
8:00am
10-K
bl0k5txis5dc qve8
9 Mar 22
Annual report
7:30am
8-K
EX-99.1
yei8v tj2ib9n
9 Mar 22
TScan Therapeutics Reports Full Year 2021 Financial Results and Highlights Key 2022 Priorities
7:13am
8-K
EX-99.1
1wk7zgcuj9qbk3tu2rmx
24 Jan 22
TScan Therapeutics Announces FDA Clearance of Investigational New Drug
7:31am
8-K
abcm11
24 Jan 22
TScan Therapeutics Announces FDA Clearance of Investigational New Drug
7:31am
8-K
EX-10.1
3wwo4n7xvk lzxy7
2 Dec 21
Entry into a Material Definitive Agreement
7:31am
10-Q
b9u8dbs5 840roh
19 Aug 21
Quarterly report
7:31am
424B4
omh31
19 Jul 21
Prospectus supplement with pricing info
7:01am
S-1/A
k7hh jqiv1cz416g2y
30 Apr 21
IPO registration (amended)
5:00pm
CORRESP
xp1wx1fqpcvh9px 2lw9
30 Apr 21
Correspondence with SEC
12:00am